Teneligliptin + Pioglitazone Fixed-Dose Combination Drug

Glenmark becomes the First Pharmaceutical Company to launch Teneligliptin + Pioglitazone Fixed-Dose Combination Drug forType 2Diabetes in India

The innovative Fixed-Dose Combination will help improving the glycemic control among adult patients with insulin resistance, those whose diabetesis uncontrolled…

3 years ago